Evidence map›Paper›PMID 41157240›Full record

ArticleLife (Basel, Switzerland)2025

Design, Structural Stability, Membrane Binding, and Antibacterial Activity of Novel Antimicrobial Peptides Derived from Wuchuanin-A1.

Rizki A Putri, Ahmad Habibie, Prajnaparamita Dhar, Krzysztof Kuczera, Respati Tri Swasono, Muhammad Saifur Rohman, Tri Joko Raharjo, Teruna J Siahaan

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rizki A PutriDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia.
Ahmad HabibieDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia.
Prajnaparamita DharDepartment of Chemical and Petroleum Engineering, School of Engineering, The University of Kansas, Eaton Hall, 1520 W 15th St, Lawrence, KS 66045, USA.ORCID 0000-0002-5821-5253
Krzysztof KuczeraDepartment of Chemistry, College of Liberal Arts & Sciences, The University of Kansas, Gray-Little Hall, 1567 Irving Hill Rd, Lawrence, KS 66045, USA.ORCID 0000-0003-2358-1349
Respati Tri SwasonoDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia.
Muhammad Saifur RohmanDepartment of Agricultural Microbiology, Universitas Gadjah Mada, Jl Flora, Kompleks Bulaksumur, UGM, Yogyakarta 55281, Indonesia.ORCID 0000-0002-7764-9778
Tri Joko RaharjoDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia.ORCID 0000-0003-0615-5241
Teruna J SiahaanDepartment of Pharmaceutical Chemistry, School of Pharmacy, The University of Kansas, Simons Laboratories, 2095 Constant Ave., Lawrence, KS 66045, USA.ORCID 0000-0001-7250-0627

Funding

Synthetic Chemical Biology CoreP20GM113117 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI OROZCO, ROBIN C. · 2016 to 2025
$23.9M
Reshaping ApoE4 and Alzheimer's Brains with ApoE2R01AG071682 · NIA · UNIVERSITY OF KANSAS LAWRENCE · PI TERUNA J. SIAHAAN, Liqin Zhao · 2022 to 2026
$3.4M
A Novel Method to Enhance Drug Delivery to the BrainR01AG082273 · NIA · UNIVERSITY OF KANSAS LAWRENCE · PI KRZYSZTOF KUCZERA, TERUNA J. SIAHAAN · 2024 to 2026
$1.4M
AVIII HD 400 NMR spectrometer to replace existing DRX 400S10OD016360 · OD · UNIVERSITY OF KANSAS LAWRENCE · PI DOUGLAS, JUSTIN TRIGALET · 2014 to 2014
$297k
NIA NIH HHS R01 AG071682NIA NIH HHS R01 AG082273NIGMS NIH HHS P20 GM113117NIH HHS 1P01GM113117-02NIH HHS 1R01AG071682-05NIH HHS 1R01AG082273-05NIH HHS S10 OD016360NIH Office of Director S10OD016360PKPI Sandwich-like program 165.27/E4.4/KU/2023PMDSU Research Grant 018/E5/PG.02.00.PL/2023; 2194/UN1/DITLIT/Dit Lit/PT.01.03/2023
6 · The paper itself

Abstract

Antibiotic resistance is a major health problem globally, highlighting the need for alternative antimicrobials that may potentially reduce the emergence of resistance compared to conventional antibiotics. Antimicrobial peptides (AMPs) are promising candidates because of their broad-spectrum activity. In this study, we designed three derivatives (i.e., Analog-1, -2, and -3) of the native peptide, Wuchuanin-A1, for improving their antibacterial activity against

Indexed as

amphipathic helixantibacterialCD spectroscopymembrane disruptionmolecular dynamics simulationsNMRpeptide modificationα-helical peptides

Identifiers

PMID41157240
PMCPMC12565435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.